
Remora appoints new chair
Biofilm prevention specialist Remora has named Martin Laudenbach as its new chair, bringing extensive international business expertise to the award-winning company.
With over 30 years in the chemical industry, Martin has held senior leadership roles at BASF and Solvay, advising global businesses on market strategy and transformation.
Martin said: “I am passionate about working with organisations which take inspiration from nature and have a real vision for sustainable growth.
“The Remora® technology offers a truly game-changing solution to harmful biofilms and I am excited to join the team and share my experience of guiding businesses to achieve commercial success.
“Remora has a talented team with a shared belief in what they are working to achieve.
“I’m looking forward to working with them on their growth journey.”
Remora, developed in Scotland, offers a sustainable, non-toxic alternative to conventional antibacterial agents, with applications in healthcare, coatings and textiles.
Martin’s appointment marks a key milestone in the company’s growth as it continues to revolutionise biofilm prevention with its cutting-edge technology.
Dr Richard Hammond, chief executive of Remora, added: “Martin's strategic vision and passion for innovation and sustainability will be instrumental in guiding Remora through its next phase of growth and development.
“His impressive track record and dedication to sustainable practices align perfectly with our values and mission.
“Martin's advice and strategic guidance will be invaluable as we continue to innovate and expand our unique biofilm prevention technology for a wide range of applications and sectors, providing safer and more sustainable solutions for our clients.”
Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning National email for free.